The heterogeneity of antipsychotic response in the treatment of schizophrenia.
about
Increased Resting-State Gamma-Band Connectivity in First-Episode SchizophreniaSocial Stress and Psychosis Risk: Common Neurochemical Substrates?The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial.Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database studyIs the PANSS used correctly? a systematic review.The use of clinical and biological characteristics to predict outcome following First Episode Psychosis.Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophreniaDisease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.A review of recent literature employing electroencephalographic techniques to study the pathophysiology, phenomenology, and treatment response of schizophrenia.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.Antipsychotic Trials in Schizophrenia from India: A Systematic Review and Meta-analysis.The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia.Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study.Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.Reduced auditory evoked gamma band response and cognitive processing deficits in first episode schizophrenia.Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.A preliminary study of association of genetic variants with early response to olanzapine in schizophrenia.
P2860
Q27320037-73C5E27A-2A80-4500-B94F-D2B3BF4F742CQ30364687-93CD7B06-77DF-4EEF-A2F9-5231B950AC46Q30702895-419A03EF-8FC2-4645-92BA-EC78190571F7Q33797431-603A7B69-9594-4769-82F9-AFFB5A4453F0Q33964357-140384ED-B4CD-4B42-904E-5BA2A29259BFQ35457414-6346AE92-5409-496A-9A4E-735FCE2C35FDQ35566098-38076C7C-FD85-447D-BF4C-4B60AEF2077DQ36902087-C2F64FE6-515D-4C64-9A48-5BE39C059BC1Q38128185-CE46ECD1-2BFA-4874-A99E-B363F8531488Q38570636-1184252C-D030-4E4B-ADF6-1A77B3F63BC2Q38777321-0854D5DC-1449-4507-B0F5-5C3ADDAD733EQ40014174-CAB39708-2742-446B-B68C-E251B62BE5ACQ40022563-883A7D9C-6CC4-49F7-93AC-79662E1891FCQ42167074-5D7EFA92-EE5E-4442-93AA-13C27EA84635Q45778269-05A910D7-FCE7-4256-92BC-87586ED2732DQ46602774-55139385-9421-4076-ABA6-759CD8CE63CFQ50746672-E566A21F-1DE9-4DEB-8A0F-AA0E8209856FQ51249633-0488F55D-3B34-47C8-BE75-877AAF36E35AQ55216457-D26EEC90-D76A-4D49-B6ED-4941DAEEDBB3Q55342505-48479AB1-215B-4788-86E4-C09EDC65DA7D
P2860
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@ast
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@en
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@nl
type
label
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@ast
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@en
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@nl
prefLabel
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@ast
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@en
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@nl
P2093
P2860
P1476
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
@en
P2093
H Ascher-Svanum
S Kollack-Walker
V L Stauffer
P2860
P304
P356
10.1017/S0033291710001893
P407
P50
P577
2010-10-07T00:00:00Z